Search Results for "methamphetamine"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for methamphetamine. Results 1 to 10 of 12 total matches.
See also: Desoxyn

Methamphetamine Abuse

   
The Medical Letter on Drugs and Therapeutics • Aug 02, 2004  (Issue 1188)
Methamphetamine Abuse ...
Methamphetamine, a highly addictive synthetic sympathomimetic, has again become important as a drug of abuse in the US. Its resurgence has been associated with unsafe sexual practices that have resulted in an increase in HIV transmission, particularly among men who have sex with men (SJ Semple et al, J Subst Abuse Treat 2002; 22:149; A Urbina and K Jones, Clin Infect Dis 2004; 38:890).
Med Lett Drugs Ther. 2004 Aug 2;46(1188):62-3 |  Show IntroductionHide Introduction

In Brief: Oral Phenylephrine for Nasal Congestion

   
The Medical Letter on Drugs and Therapeutics • Dec 21, 2015  (Issue 1484)
in the synthesis of methamphetamine. CLINICAL STUDIES — In a randomized, open-label, doseranging trial in 539 ...
In 2007, an FDA advisory committee asked that placebo-controlled, dose-ranging trials be conducted to establish the efficacy of the oral decongestant phenylephrine (Sudafed PE, and others), which is sold over the counter (OTC) as a single agent and in combination with other drugs for treatment of cold and allergy symptoms. Phenylephrine replaced pseudoephedrine (Sudafed, and others) in many OTC formulations when access to pseudoephedrine-containing products was restricted in an effort to reduce their use in the synthesis of methamphetamine.CLINICAL STUDIES — In a randomized, open-label,...
Med Lett Drugs Ther. 2015 Dec 21;57(1484):174 |  Show IntroductionHide Introduction

Adderall and Other Drugs for Attention-Deficit/Hyperactivity Disorder

   
The Medical Letter on Drugs and Therapeutics • Nov 25, 1994  (Issue 936)
, 1990). Desoxyn Gradumets (Abbott) are a form of long-acting methamphetamine marketed for treatment ...
A drug that combines the neutral sulfate salts of dextroamphetamine and racemic amphetamine with the dextro isomer of amphetamine saccharate and d,l amphetamine aspartate (Adderall - Richwood Pharmaceutical) has recently been promoted for treatment of children with Attention-Deficit/Hyperactivity Disorder (ADHD). This same mixture of amphetamine salts was previously marketed as Obetrol for treatment of obesity.
Med Lett Drugs Ther. 1994 Nov 25;36(936):109-10 |  Show IntroductionHide Introduction

Acute Reactions to Drugs of Abuse

   
The Medical Letter on Drugs and Therapeutics • Mar 04, 2002  (Issue 1125)
(Dexedrine, and others) and related sympathomimetics such as methamphetamine, propylhexadrine or ephedrine ...
Acute toxic reactions to drugs of abuse continue to be important problems. Some patients may have mixed intoxications with complex combinations of signs and symptoms.
Med Lett Drugs Ther. 2002 Mar 4;44(1125):21-4 |  Show IntroductionHide Introduction

In Brief: Over-the-Counter Narcan Nasal Spray

   
The Medical Letter on Drugs and Therapeutics • May 01, 2023  (Issue 1675)
opioids Using other illicit drugs such as methamphetamine or cocaine that could potentially ...
The FDA has approved the over-the-counter (OTC) sale of Narcan (Emergent), a nasal spray that delivers 4 mg of the opioid antagonist naloxone. Narcan nasal spray has been available by prescription since 2015 for emergency treatment of opioid overdose. Generic formulations of Narcan have also been approved; the manufacturers of these products will be required to switch them to OTC status and amend their labeling accordingly. Kloxxado, an 8-mg naloxone nasal spray, remains available only by prescription.
Med Lett Drugs Ther. 2023 May 1;65(1675):72   doi:10.58347/tml.2023.1675e |  Show IntroductionHide Introduction

In Brief: A New OTC Naloxone Nasal Spray (RiVive)

   
The Medical Letter on Drugs and Therapeutics • Mar 18, 2024  (Issue 1698)
such as methamphetamine or cocaine that could potentially be contaminated with illicit synthetic opioids like fentanyl ...
The FDA has approved RiVive (Harm Reduction Therapeutics), a 3-mg naloxone nasal spray, as an over-the-counter (OTC) product for emergency treatment of opioid overdose. Two 4-mg naloxone nasal spray formulations, Narcan and one of its generics, were approved for OTC sale in 2023.
Med Lett Drugs Ther. 2024 Mar 18;66(1698):47-8   doi:10.58347/tml.2024.1698d |  Show IntroductionHide Introduction

In Brief: Higher-Dose Naloxone Nasal Spray (Kloxxado) for Opioid Overdose

   
The Medical Letter on Drugs and Therapeutics • Sep 20, 2021  (Issue 1633)
opioids Using other illicit drugs such as methamphetamine or cocaine that could potentially ...
The FDA has approved a higher-dose intranasal naloxone formulation (Kloxxado – Hikma) for emergency treatment of opioid overdose. A single spray of the new formulation delivers 8 mg of naloxone; a formulation that delivers 4 mg per spray (Narcan) was approved in 2015.
Med Lett Drugs Ther. 2021 Sep 20;63(1633):151-2 |  Show IntroductionHide Introduction

Tests for Drugs of Abuse

   
The Medical Letter on Drugs and Therapeutics • Aug 19, 2002  (Issue 1137)
, amphetamines, dextroamphetamine, methamphetamine, selegiline, chlorpromazine, trazodone, bupropion ...
Testing for drug use has become increasingly common, not only in health care, but also in drug rehabilitation, in the military, at the workplace, after accidents and in the criminal justice system. Performance-enhancing drugs such as anabolic steroids, growth hormone (Genotropin, and others) and erythropoietin (Procrit, Epogen) are not discussed here.
Med Lett Drugs Ther. 2002 Aug 19;44(1137):71-3 |  Show IntroductionHide Introduction

Pergolide And Selegiline For Parkinson's Disease

   
The Medical Letter on Drugs and Therapeutics • Sep 08, 1989  (Issue 800)
weeks. Selegiline is metabolized to l-amphetamine and l-methamphetamine, among other metabolites ...
Levodopa combined with carbidopa (Sinemet) is the treatment of choice for Parkinson's disease (Medical Letter, 30:113, 1988). After prolonged treatment, however, the symptoms of the disease often become difficult to manage. The benefit from each dose becomes shorter (the 'wearing-off' effect), sudden fluctuations occur between mobility and immobility (the 'on-off' phenomenon), and abnormal involuntary movements (dyskinesias) may become frequent. The dopamine agonist bromocriptine (Parlodel) can ameliorate some of these effects. Two new drugs, pergolide (Permax - Lilly), another dopamine...
Med Lett Drugs Ther. 1989 Sep 8;31(800):81-3 |  Show IntroductionHide Introduction

Contrave - A Combination of Bupropion and Naltrexone for Weight Loss

   
The Medical Letter on Drugs and Therapeutics • Nov 10, 2014  (Issue 1455)
, are all controlled substances; methamphetamine has a high abuse potential and probably should not be used ...
The FDA has approved a fixed-dose combination of the opioid receptor antagonist naltrexone (ReVia, and others) and the antidepressant and smoking cessation agent bupropion (Wellbutrin SR, Zyban, and others), as Contrave (Orexigen/Takeda) for weight loss. The combination was approved for use as an adjunct to diet and increased physical activity in patients with a body mass index (BMI) ≥30 kg/m2 or a BMI ≥27 kg/m2 and one or more weight-related comorbidities such as hypertension, diabetes, or dyslipidemia. Naltrexone/bupropion is not a controlled...
Med Lett Drugs Ther. 2014 Nov 10;56(1455):112-4 |  Show IntroductionHide Introduction